Invesco
LPCN icon

Invesco’s Lipocine LPCN Stock Holding History

Invesco’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-62,632
Closed -$4.15M – 3708
2017
Q1 		$4.15M Sell
62,632
-687
-1% -$44.5K ﹤0.01% 2113
2016
Q4 		$3.96M Buy
63,319
+52
+0.1% +$3.29K ﹤0.01% 2120
2016
Q3 		$4.8M Sell
63,267
-4
-0% -$248 ﹤0.01% 2005
2016
Q2 		$3.27M Buy
63,271
+36
+0.1% +$5.58K ﹤0.01% 2203
2016
Q1 		$10.9M Hold
63,235
– – ﹤0.01% 1396
2015
Q4 		$13.9M Hold
63,235
– – 0.01% 1321
2015
Q3 		$12.7M Hold
63,235
– – 0.01% 1343
2015
Q2 		$9.22M Buy
+63,235
New +$7.85M ﹤0.01% 1589

Other funds holding LPCN

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Invesco's LPCN Position: Q2 2017 in Review

Invesco sold out of Lipocine (LPCN) in Q2 2017, closing a stake of 62,632 shares — an estimated $4.15M sold.

Invesco first reported a position in LPCN in Q2 2015 and held it in 8 quarters. The position peaked at $13.9M in Q4 2015. 42 funds tracked by Wall St. Rank hold LPCN as of Q2 2017.

  • Invesco reported no remaining Lipocine position as of Q2 2017 after selling out during the quarter.
  • Invesco sold 62,632 Lipocine shares in Q2 2017, an estimated $4.15M.
  • Invesco first reported a position in Lipocine in Q2 2015 and held it in 8 quarters.
  • Invesco's Lipocine position peaked at $13.9M in Q4 2015.
  • 42 funds tracked by Wall St. Rank held Lipocine as of Q2 2017.

Based on Invesco's 13F filing for Q2 2017, filed 14 Aug 2017.